Vivos Therapeutics Inc (VVOS) USD0.0001

Sell:$3.74Buy:$3.82$0.09 (2.31%)

Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.82
Change:$0.09 (2.31%)
Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.82
Change:$0.09 (2.31%)
Prices delayed by at least 15 minutes

Company Information

About this company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.

Key people

R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Bradford K. Amman
Chief Financial Officer
Ralph E. Green
Independent Director
Anja B. Krammer
Independent Director
Mark F. Lindsay
Independent Director
Leonard J. Sokolow
Independent Director
Matthew Thompson
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US92859E2072
  • Market cap
    $22.97m
  • Employees
    114
  • Shares in issue
    5.89m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.